|
1
|
Li J, Yen C, Liaw D, Podsypanina K, Bose
S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, et al:
PTEN, a putative protein tyrosine phosphatase gene mutated in human
brain, breast, and prostate cancer. Science. 275:1943–1947.
1997.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Teng DH, Hu R, Lin H, Davis T, Iliev D,
Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, et al:
MMAC1/PTEN mutations in primary tumor specimens and tumor cell
lines. Cancer Res. 57:5221–5225. 1997.PubMed/NCBI
|
|
3
|
Eng C: PTEN hamartoma tumor syndrome. Gene
reviews https://www.ncbi.nlm.nih.gov/books/NBK1488/
Accessed 1 March 2017.
|
|
4
|
Herman GE, Butter E, Enrile B, Pastore M,
Prior TW and Sommer A: Increasing knowledge of PTEN germline
mutations: Two additional patients with autism and macrocephaly. Am
J Med Genet A = 143A. 589–593. 2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Varga EA, Pastore M, Prior T, Herman GE
and McBride KL: The prevalence of PTEN mutations in a clinical
pediatric cohort with autism spectrum disorders, developmental
delay, and macrocephaly. Genet Med. 11:111–117. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kurek KC, Howard E, Tennant LB, Upton J,
Alomari AI, Burrows PE, Chalache K, Harris DJ, Trenor CC III, Eng
C, et al: PTEN hamartoma of soft tissue: A distinctive lesion in
PTEN syndromes. Am J Surg Pathol. 36:671–87. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
NCCN Clinical Practice Guidelines in
OncologyVersion 3. 2019 Cowden syndrome/PHTS. NCCN Guidelines®:
https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf.
Accessed 8 May 2019.
|
|
8
|
Society for the Kyoto scale of
psychological development test. Shinpan K Shiki Hattatsu Kensahou
2001 Nenban (The Kyoto Scale of Psychological Development Test
2001). Kyoto, Japan: Nakanishiya Shuppan, 2008.
|
|
9
|
Iwama K, Osaka H, Ikeda T, Mitsuhashi S,
Miyatake S, Takata A, Miyake N, Ito S, Mizuguchi T and Matsumoto N:
A novel SLC9A1 mutation causes cerebellar ataxia. J Hum Genet.
63:1049–1054. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
D'Gama AM, Pochareddy S, Li M, Jamuar SS,
Reiff RE, Lam AN, Sestan N and Walsh CA: Targeted DNA sequencing
from autism spectrum disorder brains implicates multiple genetic
mechanisms. Neuron. 88:910–917. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Tan MH, Mester J, Peterson C, Yang Y, Chen
JL, Rybicki LA, Milas K, Pederson H, Remzi B, Orloff MS and Eng C:
A clinical scoring system for selection of patients for PTEN
mutation testing is proposed on the basis of a prospective study of
3042 probands. Am J Hum Genet. 88:42–56. 2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Bermúdez Brito M, Goulielmaki E and
Papakonstanti EA: Focus on PTEN regulation. Front Oncol.
5(166)2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Perren A, Weng LP, Boag AH, Ziebold U,
Thakore K, Dahia PL, Komminoth P, Lees JA, Mulligan LM, Mutter GL
and Eng C: Immunohistochemical evidence of loss of PTEN expression
in primary ductal adenocarcinomas of the breast. Am J Pathol.
155:1253–1260. 1999.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Vanderver A, Tonduti D, Kahn I, Schmidt J,
Medne L, Vento J, Chapman KA, Lanpher B, Pearl P, Gropman A, et al:
Characteristic brain magnetic resonance imaging pattern in patients
with macrocephaly and PTEN mutations. Am J Med Genet A.
164A:627–633. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Bhargava R, Au Yong KJ and Leonard N:
Bannayan-Riley-Ruvalcaba syndrome: MRI neuroimaging features in a
series of 7 patients. Am J Neuroradiol. 35:402–406. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Rodríguez-Escudero I, Oliver MD,
Andrés-Pons A, Molina M, Cid VJ and Pulido R: A comprehensive
functional analysis of PTEN mutations: Implications in tumor- and
autism-related syndromes. Hum Mol Genet. 20:4132–4142.
2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Nelen MR, van Staveren WC, Peeters EA,
Hassel MB, Gorlin RJ, Hamm H, Lindboe CF, Fryns JP, Sijmons RH,
Woods DG, et al: Germline mutations in the PTEN/MMAC1 gene in
patients with Cowden disease. Hum Mol Genet. 6:1383–1387.
1997.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Eng C: PTEN: One gene, many syndromes. Hum
Mutat. 22:183–198. 2003.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hansen-Kiss E, Beikampen S, Adler B,
Frazier T, Prior T, Erdman S, Eng C and Herman G: A retrospective
chart review of the features of PTEN hamartoma tumour syndrome in
children. J Med Genet. 54:471–478. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Butler MG, Dasouki MJ, Zhou XP,
Talebizadeh Z, Brown M, Takahashi TN, Miles JH, Wang CH, Stratton
R, Pilarski R and Eng C: Subset of individuals with autism spectrum
disorders and extreme macrocephaly associated with germline PTEN
tumour suppressor gene mutations. J Med Genet. 42:318–321.
2005.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Tan MH, Mester JL, Ngeow J, Rybicki LA,
Orloff MS and Eng C: Lifetime cancer risks in individuals with
germline PTEN mutations. Clin Cancer Res. 18:400–407.
2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Smpokou P, Fox VL and Tan WH: PTEN
hamartoma tumour syndrome: Early tumour development in children.
Arch Dis Child. 100:34–37. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Pilarski R: PTEN hamartoma tumor syndrome:
A clinical overview. Cancers (Basel). 11(E844)2019.PubMed/NCBI View Article : Google Scholar
|
